Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2349 of 5804
-
Osteopathy plus diet may ease IBS in fibromyalgia patients
Symptom relief Recruiting nowDietary modifications are often recommended as first-line treatment for irritable bowel syndrome, with the FODMAP diet being the most effective intervention to improve global gastrointestinal symptoms. Due to the heterogeneity of symptoms, patients often seek complementary or alt…
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Can a nighttime breathing machine ease severe COPD?
Disease control Not yet recruitingThis study aims to evaluate the impact of long-term home non-invasive ventilation (NIV) on patients with COPD
Phase: NA • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Faith and fitness: new study tests church program to fight heart disease in black men
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the implementation and effectiveness of the FELLAship program-a church-based cardiovascular health (CVH) intervention-in Black men aged 35-70 who are at risk for heart disease, diabetes, obesity, and related conditions. The main ques…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
AR glasses may revolutionize vertigo diagnosis
Diagnosis Recruiting nowBackground and Purpose: Vertigo is common in emergency and outpatient settings, yet standard oculomotor testing usually requires dedicated equipment and exam rooms. This study evaluates whether nystagmus examinations performed with wearable augmented-reality (AR) glasses are equ…
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Diagnosis
Last updated Jul 11, 2026 00:00 UTC
-
Double antibiotic attack: could a combo therapy beat strep in the blood?
Disease control Not yet recruitingA double-blind randomized controlled trial comparing beta-lactam plus levofloxacin versus beta-lactam monotherapy for the treatment of Streptococcal bacteremia
Phase: PHASE4 • Sponsor: Mahidol University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can exercise ease chemo nerve damage? new trial tests shorter programme
Symptom relief Not yet recruitingChemotherapy is a cornerstone in the treatment of colon cancer; however, its effects extend beyond malignant cells. Because chemotherapeutic agents target rapidly dividing cells, they can also damage healthy tissues, resulting in a range of adverse effects. Among the most prevale…
Phase: NA • Sponsor: University of Salamanca • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New nerve block aims to stop chronic pain after mastectomy
Symptom relief Not yet recruitingRadical mastectomy is currently the mainstream surgical treatment for breast cancer. Patients often experience significant postoperative pain, and some may develop chronic pain. General anesthesia is commonly used, with remifentanil being the most frequently used intraoperative a…
Phase: PHASE1, PHASE2 • Sponsor: First Affiliated Hospital of Kunming Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Could a pill every other day be just as good for prostate symptoms?
Symptom relief Not yet recruitingBackground: Lower urinary tract symptoms (LUTS) are common in aging men, most often due to benign prostatic hyperplasia (BPH), and significantly impair quality of life. α1-adrenoceptor antagonists are first-line therapy, with tamsulosin being the most widely prescribed. However,…
Phase: PHASE4 • Sponsor: Mansoura University • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Can herbal granules protect kidneys in IgA disease?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if Shenqi Yishen Granules works to treat IgA Nephropathy in adults. It will also learn about the safety of Shenqi Yishen Granules. The main questions it aims to answer are: Does Shenqi Yishen Granules lower 24-hour urinary protein quan…
Phase: NA • Sponsor: Keda Lu • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Poop pills for autism? small study tests gut bacteria fix
Disease control Not yet recruitingThe aim of the study is to evaluate the effectiveness and safety of fecal microbiota transplantation (FMT) in reducing gastrointestinal (GI) and behavioral symptoms in children with autism spectrum disorder (ASD). Children with ASD often experience GI problems such as constipati…
Phase: NA • Sponsor: Institute of Mother and Child, Warsaw, Poland • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a PET scan spot heart trouble in fabry disease before It's too late?
Knowledge-focused Not yet recruitingIn this work, we address the understanding of the signaling pathways involved in cardiac remodeling in human SCD through molecular imaging analysis with a fibrosis marker. Furthermore, we emphasize characterizing the cardiac remodeling process by analyzing proteomic data from SCD…
Sponsor: Núcleo de Apoio à Investigação Clínica - FMUP • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Brain games boost Seniors' minds in new study
Symptom relief Recruiting nowThe research aims to investigate the effectiveness a cognitive stimulation therapy group for older adults with dementia and mild cognitive impairment living in residential homes. This study adopts a multicenter randomized control trial two arms research design. The randomized co…
Phase: NA • Sponsor: City University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New antibody shot could shield against Tick-Borne brain virus
Prevention Not yet recruitingThe goal of this clinical trial is to evaluate the safety, tolerability, and pharmacokinetics of the investigational monoclonal antibody TBE025 when given intravenously to healthy adult volunteers aged 18 to 55. The study aims to determine the recommended Phase II dose of TBE025…
Phase: PHASE1 • Sponsor: Giuseppe Pantaleo • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
New digital tool aims to cut fall risk for MS patients
Disease control Not yet recruitingPeople with multiple sclerosis (MS) have a higher fall risk compared to older people and to the general population. A meta-analysis reported that 56% of those with mild to moderate MS, fell at least once during a 3-month period. The risk of falling seems to peak when the walking …
Phase: NA • Sponsor: Region Örebro County • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a common RA drug also protect your heart and blood?
Disease control Not yet recruitingThis prospective interventional study aims to evaluate the effects of baricitinib on disease activity, lipid profile, atherogenic index, and procoagulant biomarkers including monocyte-derived human tissue factor and D-dimer in patients with rheumatoid arthritis, compared with con…
Phase: PHASE4 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New DNA scanner could speed up treatment for diabetic foot infections
Diagnosis Recruiting nowDiabetic foot wound infections are predominantly polymicrobial. However, 'conventional' microbiological culture does not identify all the bacteria potentially involved in these infections and requires time, which can have a negative impact by delaying treatment and/or the prescri…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
Could a simple supplement help preterm babies breathe better?
Disease control Recruiting nowThe current study is planned to see the effect of L-carnitine supplementation in preterm neonates suffering from RDS among the local population, as there is no such evidence available for the local population and there are conflicting statistics regarding the discharge rate of th…
Phase: NA • Sponsor: Muhammad Aamir Latif • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could brain zaps and diet fix Crohn's constipation?
Symptom relief Recruiting nowFifty six patients with Crohn's disease of both genders with age 40 - 60 year old suffering from constipation, physical and functional limitations participated in this study. The participants were selected from Outpatient clinic of Faculty of Physical Therapy, Suez Canal Universi…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New hair loss gel takes on minoxidil in Head-to-Head trial
Symptom relief Recruiting nowAndrogenetic alopecia is a common form of hair loss that can affect quality of life. This randomized controlled trial aims to evaluate the efficacy and safety of topical 2-Deoxy-D-ribose (2dDR) hydrogel compared with topical minoxidil 5% solution in the treatment of mild to moder…
Phase: NA • Sponsor: Kasr El Aini Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New ultrasound test could spot painful fat disorder often mistaken for obesity
Diagnosis CompletedLipedema is a chronic disorder characterized by abnormal bilateral fat deposition in the extremities, predominantly affecting women and typically beginning at puberty. The trunk, hands, and feet are usually spared. Despite its relatively high prevalence, lipedema is frequently un…
Sponsor: Fatih Sultan Mehmet Training and Research Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:08 UTC